Integrin α3β1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes

Journal of Cellular Biochemistry

Volumn 72, Issue 2, 1999, Pages 189-209

  Prokopishyn, Nicole L ^a,c   Puzon McLaughlin, Wilma ^b   Takada, Yoshikazu ^b   Laferté, Suzanne ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Gene Cell Inc   (United States)

Author keywords

Cancer; Carbohydrate epitopes; Colon; Colorectal carcinoma

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; CARBOHYDRATE; EPITOPE; GLYCOPROTEIN GP 140; INTEGRIN; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; SIALOGLYCOPROTEIN; GLYCOPROTEIN; VERY LATE ACTIVATION ANTIGEN 3;

ANIMAL CELL; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP B; CANCER CELL; CHO CELL; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CELL STRAIN HT29; CHEMISTRY; COLON TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HAMSTER; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PEPTIDE MAPPING; PHYSIOLOGY; SERODIAGNOSIS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARBOHYDRATES; CHO CELLS; COLONIC NEOPLASMS; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HT29 CELLS; HUMANS; INTEGRIN ALPHA3BETA1; INTEGRINS; MICE; OLIGOSACCHARIDES; PEPTIDE MAPPING; PRECIPITIN TESTS; TUMOR CELLS, CULTURED;

EID: 0033073933     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990201)72:2<189::AID-JCB4>3.0.CO;2-N     Document Type: Article

References (92)

1. Aebersold RH, Leavitt J, Saavedra RA, Hood LE, Kent SBH. 1987. Internal amino acid sequence analysis of proteins separated by one- and two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose. PNAS 84:6970-6974.
2. Atkinson BF, Ernst CS, Herlyn M, Steplewshi Z, Sears HF, Koprowski H. 1982. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res 42:4820-4823.
3. a epitope on distinct core glycoprotiens. J Biol Chem 266:21537-21547.
4. Bird RP, Mercer NJH, Draper HH. 1985. Animal models for the study of nutrition and human disease: Colon cancer, atherosclerosis and osteoporosis. In: Draper HH, editor. Advances in Nutritional Research. Vol 7. New York: Plenum Press, pp 155-186.
5. Bonner WM, Laskey RA. 1974. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem 46:83-88.
6. Bretscher MS. 1988. Fibroblasts on the move. J Cell Biol 106:235-237.
7. Bloom EJ, Itzkowitz SH, Kim YS. 1990. Carbohydrate tumor markers in colon cancer and polyps. In: Moyer MP, Post GH, editors. Colon cancer cells. San Diego, CA: Academic Press. p 429-451.
8. Canadian Cancer Statistics. 1997. Statistics Canada, Health Canada, National Cancer Institute of Canada and Provincial Cancer Registries.
9. Carlsson SR, Roth J, Piller F, Fukuda M. 1988. Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycans. J Biol Chem 263: 18911-18919.
10. Carson DD. 1992. Proteoglycans in development. In: Fukuda M, editor. Cell surface carbohydrates and cell development. Boca Raton, FL: CRC Press. p 258-283.
11. Carter WG, Ryan MC, Gahr PJ. 1991. Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 65:599-610.
12. Castronovo V, Collin C, Parent B, Foidart JM, Lambotte R, Mahieu P. 1989. Possible role of human natural anti-gal antibodies in the natural antitumor defense system. J Natl Cancer Inst 81:212-216.
13. Chammas R, Veiga SS, Travassos LR, Brantani RR. 1993. Functionally distinct roles for glycosylation of α and β integrin chains in cell-matrix interactions. Proc Natl Acad Sci USA 90:1795-1799.
14. Chandrasekaran EV, Davila M, Nixon DW, Goldfarb M, Mendicino J. 1983. Isolation and structures of the oligosaccharide units of carcinoembyonic antigen. J Biol Chem 258:7213-7222.
15. Cleveland DW, Fischer SG, Kirschner MW, Laemmli UK. 1977. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis in gel electrophoresis. J Biol Chem 252:1102-1106.
16. Coon JS, Weinstein RS. 1986. Flow cytometric analysis of paraffin-embeded tumors: Implications for diagnostic pathology. Hum Pathol 17:1089-1106.
17. Dabelsteen E, Graem N, Clausen H, Hakomori SI. 1988. Structural variations of blood group A antigens in human normal colon and carcinomas. Cancer Res 48:181-187.
18. Dedhar S, Jewell K, Rojiani M, Gary V. 1992. The receptor for the basement membrane glycoprotein entactin is the integrin alpha3/beta1. J Biol Chem 267:18908-18914.
19. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. 1995. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 130:383-392.
20. Denk H, Tappeiner G, Holzner JH. 1974. Blood group substances as carcinofetal antigens in carcinomas of the distal colon. Eur J Cancer 10:487-490.
21. Dennis JW. 1992. Changes in glycosylation associated with malignant transformation and tumor progression. In: Fukuda M, editor. Cell surface carbohydrates and cell development. Boca Raton, FL: CRC Press. p 161-194.
22. Dennis JW, Laferté S. 1985. Recognition of asparagine-linked oligosaccharides on tumor cells by natural killer cells. Cancer Res 45:6034-6040.
23. Dennis JW, Laferté S, Waghorne C, Breitman ML, Kerbel RS. 1987. β1-6 branching on complex-type Asn-linked oligosaccharides is directly associated with metastasis. Science 236:582-585.
24. DiPersio CM, Hodivala-Dilke KM, Jaenisch R, Kreidberg JA, Hynes RO. 1997. Alpha3beta1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol 137:729-742.
25. Ernst C, Thurin J, Atkinson B, Weirzel H, Herlyn M, Stromberg N, Cevin C, Koprowski H. 1984. Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am J Pathol 117:451-461.
26. Etzler ME, Kabat EA. 1970. Purification and characterization of a lectin (plant hemagglutinin) with blood group A specificity from Dolichos biflorus. Biochemistry 9:869-877.
27. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
28. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. 1991. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 51:718-723.
29. Fogh J, Trempe G. 1975. Human tumor cells in vitro. New York: Plenum Press. p 115-159.
30. Fukuda M. 1992. Cell surface carbohydrates in hematopoietic cell differentiation and malignancy. In: Fukuda M, editor. Cell surface carbohydrates and cell development. Boca Raton, FL: CRC Press. p 127-159.
31. Fukuda M. 1994. Cell surface carbohydrates: cell-type specific expression. In: Fukuda M, Hindsgaul O, editor. Molecular glycobiology. New York: IRL Press. p 1-52.
32. 6). J Biol Chem 259:10511-10517.
33. Hakomori SI, Kannagi R. 1983. Glycosphingolipids as tumor associated and differentiation markers. J Natl Cancer Inst 71:231-251.
34. Hammarstrom SM, Murphy LA, Goldstein IJ, Etzler ME. 1977. Carbohydrate binding specificity of four N-acetyl-D-galactosamine-specific lectins: Helix pomatia A hemagglutinin, soybean agglutinin, lima bean lectin, and Dolichos biflorus lectin. Biochemistry 16:2750-2755.
35. Harlow E, Lane D. (eds) 1988. Antibodies: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. p 148-242.
36. x antigen in liver metastases of human colorectal carcinoma. Cancer Res 49:6883-6888.
37. Hynes RO. 1992. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
38. Ichikawa D, Handa K, Withers DA, Hakomori S. 1997. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: Approach with A and B gene transfection. Cancer Res 57:3092-3096.
39. Izumi K, Yamamoto K, Tochikura T, Hirabayashi Y. 1992. Serological study using alpha-N-acetylgalactosaminidase from Acremonium sp. Biochim Biophys Acta 1116: 72-74.
40. Jasiulionis MG, Chammas R, Ventura AM, Travassos LR, Brentani RR. 1996. α6β1 integrin, a major cell surface carrier of β1-6 branched oligosaccharides, mediates migration of EJ-ras-transformed fibroblasts on laminin-1 independently of its glycosylation state. Cancer Res 56: 1682-1689.
41. Jessup JM, Gallick GE. 1992. The biology of colorectal carcinoma. Curr Probl Cancer 16:264-327.
42. Jin F, Chammas R, Engel J, Reinhold V. 1995. Structure and function of laminin 1 glycans: Glycan profiling. Glycobiology 5:157-158.
43. Kamata T, Takada Y. 1994. Direct binding of collagen to the I domain of integrin alpha2beta1 (VLA-2, CD49b/CD29) in a divalent cation-independent manner. J Biol Chem 269:26006-26010.
44. Kamata T, Puzon W, Takada Y. 1995. Identification of putative ligand-binding sites of the integrin alpha4beta1 (VLA-4, CD49d/CD29). Biochem J 305:945-951.
45. Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, Kiraiwa N, Fukuda Y, Inamoto T, Hakomori S, Imura H. 1986. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res 46:2619-2626.
46. Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170.
47. Koths K, Taylor E, Halenbeck R, Casipit C, Wang A. 1993. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 268:14245-14249.
48. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
49. Laferté S and Dennis JW. 1989. Purification of two glycoproteins expressing β1-6 branched Asn-linked oligosaccharides from metastatic tumor cells. Biochem J 259:569-576.
50. Laferté S, Loh LC. 1992. Characterization of a family of structurally related glycoproteins expressing β1-6 branched asparagine-linked oligosaccharides in human colon cancer cells. Biochem J 283:193-201.
51. Laferté S, Prokopishyn NL, Moyana T, Bird RP. 1995. A monoclonal antibody recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane-induced rat colon tumors and human colon cancer cell lines. J. Cell Biochem 57:101-119.
52. Lampe BV, Stallmach A, Riecken EO. 1992. Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. Gut 34:829-836.
53. Leibovitz A, Stenson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND. 1976. Classification of human colorectal adhenocarcinoma cell lines. Cancer Res 36:4562-4569.
54. Leppa S, Heino J, Jalkanen M. 1995. Increased glycosylation of beta 1 integrins affects the interaction of transformed S115 mammary epithelial cells with laminin-1. Cell Growth Diff 6:853-861.
55. Lindmark G, Gerdin B, Pahlman L, Glimelius B, Gehlsen K, Rubin K. 1993. Interconnection of integrins alpha 2 and alpha 3 and structure of the basal membrane in colorectal cancer: Relation to survival. Eur J Surg Oncol 19:50-60.
56. Loh LC. 1991. Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus. Virology 180:239-250.
57. Lowe JB, Stoolman LM, Nair RP, Larsen RD, Berhend TL, Marks RM. 1990. E-selectin-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell 63:475-484.
58. Lowe JB. 1994. Carbohydrate recognition in cell-cell interaction. In: Fukuda M, Hindsgaul O, editors. Molecular glycobiology. New York: IRL Press. p 163-205.
59. Matsumoto H, Muramatsu H, Shimotakahara T, Yanagi M, Nishijima H, Mitani N, Baba K, Muramatsu T, Simazu H. 1993. Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas. Cancer 72:75-81.
60. Merkle RK, Curomings RD. 1987. Lectin affinity chromatography of glycopeptides. Meth Enzymol 138:232-259.
61. Morikawa K, Walker SM, Jessup JM, Fidler IJ. 1988. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 48:1943-1948.
62. Nicolson GL. 1984. Cell surface molecules and tumor metastasis. Regulation of metastatic phenotype diversity. Exp Cell Res 150:3-22.
63. Nicolson GL. 1988. Cancer metastasis: Tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 948:175-224.
64. Nicolson GL. 1994. Tumor cell adhesion and growth properties in organ preference of tumor metastasis. Adv Mol Cell Biol 9:123-152.
65. Olden K. 1993. Adhesion molecules and inhibitors of glycosylation in cancer. Semin Ca Biol 4:269-276.
66. Orntoft TF, Meldgaard P, Pedersen B, Wolf H. 1996. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res 56:1031-1036.
67. Osawa T, Tsuji T. 1987. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Ann Rev Biochem 56:21-42.
68. Parker S, Tong T, Bolden S, Wingo P. 1997. Cancer statistics. CA Cancer J Clin 47:5-27.
69. x. Science 250:1130-1132.
70. Pierce M, Arango J. 1986. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetra-antennary glycoprotides containing [GlcNAc-β(1,6)Man-α(1,6)Man] and poly-N-acetyl-lactosamine sequences than baby hamster kidney cells. J Biol Chem 261:10772-10777.
71. Rademacher TW, Parekh RB, Dwek RA. 1988. Glycobiology. Annu Rev Biochem 57:785-838.
72. Sairam MR, Jiang LG. 1992. Comparison of the biological and immunological properties of glycosylation deficient human chorionic gonadotropin variants produced by site directed mutagenesis and chemical deglycosylation. Mol Cell Endocrinol 85:227-235.
73. Saitoh O, Wang WL, Lotan R, Fukuda M. 1992. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potential. J Biol Chem 267:5700-5711.
74. Sawada R, Tsuboi S, Fukuda M. 1994. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic properties. J Biol Chem 269:1425-1431.
75. Sechler JL, Takada Y, Schwarzbauer JE. 1996. Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J Cell Biol 134:573-583.
76. Sonnenberg A. 1993. Integrins and their ligands. Curr Topic Microbiol Immunol 184:7-35.
77. Sriramarao P, Steffner P, Gehlsen KR. 1993. Biochemical evidence for a homophilic interaction of the α3β1 integrin. J Biol Chem 268:22036-22041.
78. Symington BE, Takada Y, Carter WG. 1993. Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion. J Cell Biol 120: 523-535.
79. Szulman AE. 1962. The histological distribution of blood group substances in man as disclosed by immunofluorescence. II. The H antigen and its relation of A and B antigens. J Exp Med 115:977-995.
80. Takada Y, Murphy E, Pil P, Chen C, Ginsberg MH, Hemler ME. 1991. Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha3 beta1 (VLA-3), an integrin receptor for fibronectin, laminin and collagen. J Cell Biol 115:257-266.
81. Takada Y, Wayner EA, Carter WG, Hemler ME. 1988. Extracellular matrix receptors, ECMRII and ECMRI, for collagen and fibronectin correspond to VLA-2 and VLA-3 in the VLA family of heterodimers. J Cell Biochem 37:385-393.
82. Takada Y, Ylanne J, Mandelman D, Puzon W, Ginsberg MH. 1992. A point mutation of integrin beta 1 subunit blocks binding of alpha5beta1 to fibronectin and invasion but not recruitment to adhesion plaques. J Cell Biol 119:913-921.
83. Tomita N, Jiang W, Hibshoosh H, Kahn SM, Weinstein IB. 1992. Isolation and characterization of a highly malignant variant of the SW480 human colon cancer cell line. Cancer Res 52:6840-6847.
84. Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, Dreps A, Azam M, Rubinstein, Natoli C, Shawver LK, Schlessinger J, Iacobelli S. 1994. The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem 269:18401-18407.
85. van den Eijnden DH, Koenderman AHL, Schiporst WECM. 1988. Biosynthesis of blood group i-active polylactos-aminoglycans. J Biol Chem 263:12461-12471.
86. Varki A. 1993. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3:97-130.
87. x determinant on myeloid and tumor cells. Science 250:1132-1135.
88. Yagel S, Feinmesser R, Waghorne C, Lala PK, Breitman ML, Dennis JW. 1989. Evidence that β1-6 branched oligosaccharides on metastatic tumor cells facilitate their invasion of basement membranes. Int J Cancer 44:685-690.
89. Yeh J, Cummings RD. 1997. Differential recognition of glycoprotein acceptors by terminal glycosyltransferases. Glycobiology 7:241-251.
90. y in human normal, fetal and malignant tissue. Cancer Res 45:4499-4511.
91. Zheng M, Fang H, Hakomori SI. 1994. Functional role of N-glycosylation in α5β1 integrin receptor. J Biol Chem 269: 12325-12331.
92. Zhou Q, Cummings RD. 1992. Animal lectins: A distinct group of carbohydrate binding proteins involved in cell adhesion, molecular recognition and development. In: Fukuda M, editor. Cell surface carbohydrates and cell development. Boca Raton, FL: CRC Press. p 100-126.